HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2016-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2016 . Quarter ended March 31, 2016 Highlights - compared to March 31, 2015 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Aug. 10, 2016-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2016 . Quarter ended June 30, 2016 Highlights - compared to June 30, 2015 Net sales of $233.8
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Nov. 8, 2016-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2016 . Quarter ended September 30, 2016 Highlights - compared to September 30, 2015
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 9, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2016 . Quarter ended December 31, 2016 Highlights - compared to December 31, 2015
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 22, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and fiscal year ended March 31, 2017 . Quarter ended March 31, 2017 Highlights - compared to March 31, 2016 Net
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Aug. 8, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2017 . Quarter ended June 30, 2017 Highlights - compared to June 30, 2016 Net sales of $161.3
Alerts are e-mailed to you whenever certain new company information is posted to this site.